News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Shire Buys Rare Disease Drug Developer
Tracy Vence | Nov 2, 2015
The Irish drugmaker is set to acquire the Massachusetts-based Dyax in a $5.9 billion deal.
Kate Yandell | Sep 1, 2015
For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.
Legionnaires’ Bacteria at GSK
Jef Akst | Aug 14, 2015
GlaxoSmithKline temporarily shuts down a manufacturing plant in North Carolina after
bacteria are detected in two external cooling towers.
Teva Buys Allergan Generics for $40.5 Billion
Tracy Vence | Jul 27, 2015
Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal.
AbbVie Wins Bidding War for Cancer Drugmaker
Bob Grant | Mar 5, 2015
The pharmaceutical firm beat out a host of potential suitors, Johnson & Johnson among them, to strike a $21 billion deal with Pharmacyclics.
Pfizer to Acquire Hospira
Bob Grant | Feb 5, 2015
The pharmaceutical giant is purchasing the injectable drugmaker for about $15 billion.
Kate Yandell | Feb 1, 2015
While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.
Roche Buys Bioinformatics Firm
Bob Grant | Dec 22, 2014
The pharmaceutical giant will pay an undisclosed price to acquire Bina Technologies.
Merck Buys Cubist for $8.4B
Bob Grant | Dec 11, 2014
Hours after the pharmaceutical giant announced the acquisition, a federal judge invalidated key patents behind the antibiotic maker’s most lucrative product.
Taking Shots at Ebola
Molly Sharlach | Nov 5, 2014
With an infusion of public and private resources and accelerated regulatory processes, a handful of companies are racing to develop a vaccine to curb the Ebola epidemic.